{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:38:13Z","timestamp":1778794693466,"version":"3.51.4"},"reference-count":95,"publisher":"Portland Press Ltd.","issue":"17","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Increased level of C-reactive protein (CRP) is a risk factor for cardiovascular diseases, including myocardial infarction and hypertension. Here, we analyzed the effects of CRP overexpression on cardiac susceptibility to ischemia\/reperfusion (I\/R) injury in adult spontaneously hypertensive rats (SHR) expressing human CRP transgene (SHR-CRP). Using an in vivo model of coronary artery occlusion, we found that transgenic expression of CRP predisposed SHR-CRP to repeated and prolonged ventricular tachyarrhythmias. Excessive ischemic arrhythmias in SHR-CRP led to a significant reduction in infarct size (IS) compared with SHR. The proarrhythmic phenotype in SHR-CRP was associated with altered heart and plasma eicosanoids, myocardial composition of fatty acids (FAs) in phospholipids, and autonomic nervous system imbalance before ischemia. To explain unexpected IS-limiting effect in SHR-CRP, we performed metabolomic analysis of plasma before and after ischemia. We also determined cardiac ischemic tolerance in hearts subjected to remote ischemic perconditioning (RIPer) and in hearts ex vivo. Acute ischemia in SHR-CRP markedly increased plasma levels of multiple potent cardioprotective molecules that could reduce IS at reperfusion. RIPer provided IS-limiting effect in SHR that was comparable with myocardial infarction observed in na\u00efve SHR-CRP. In hearts ex vivo, IS did not differ between the strains, suggesting that extra-cardiac factors play a crucial role in protection. Our study shows that transgenic expression of human CRP predisposes SHR-CRP to excess ischemic ventricular tachyarrhythmias associated with a drop of pump function that triggers myocardial salvage against lethal I\/R injury likely mediated by protective substances released to blood from hypoxic organs and tissue at reperfusion.<\/jats:p>","DOI":"10.1042\/cs20210648","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T21:32:35Z","timestamp":1630963955000},"page":"2143-2163","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Excess ischemic tachyarrhythmias trigger protection against myocardial infarction in hypertensive rats"],"prefix":"10.1042","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-9992","authenticated-orcid":false,"given":"Jan","family":"Neck\u00e1\u0159","sequence":"first","affiliation":[{"name":"Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Al\u00e1nov\u00e1","sequence":"additional","affiliation":[{"name":"Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Olejn\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[{"name":"Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franti\u0161ek","family":"Papou\u0161ek","sequence":"additional","affiliation":[{"name":"Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Hejnov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"\u0160ilhav\u00fd","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics of Model Diseases, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Behuliak","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Hypertension, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Bencze","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Hypertension, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Hrdli\u010dka","sequence":"additional","affiliation":[{"name":"Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Vecka","sequence":"additional","affiliation":[{"name":"4th Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Jarkovsk\u00e1","sequence":"additional","affiliation":[{"name":"Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"\u0160v\u00edglerov\u00e1","sequence":"additional","affiliation":[{"name":"Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli\u0161ka","family":"Mistrov\u00e1","sequence":"additional","affiliation":[{"name":"Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"\u0160tengl","sequence":"additional","affiliation":[{"name":"Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Novotn\u00fd","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohuslav","family":"O\u0161\u0165\u00e1dal","sequence":"additional","affiliation":[{"name":"Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Pravenec","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics of Model Diseases, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franti\u0161ek","family":"Kol\u00e1\u0159","sequence":"additional","affiliation":[{"name":"Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"2021113011234377800_B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2015.04.010","article-title":"Possible mechanisms of C-reactive protein mediated acute myocardial infarction","volume":"760","author":"Fordjour","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"2021113011234377800_B2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2796.2008.02015.x","article-title":"C-reactive protein and coronary heart disease: a critical review","volume":"264","author":"Casas","year":"2008","journal-title":"J. Intern. Med."},{"key":"2021113011234377800_B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/138920112798868764","article-title":"Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches","volume":"13","author":"Calabro","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"2021113011234377800_B4","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2021113011234377800_B5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nature04672","article-title":"Targeting C-reactive protein for the treatment of cardiovascular disease","volume":"440","author":"Pepys","year":"2006","journal-title":"Nature"},{"key":"2021113011234377800_B6","first-page":"55","article-title":"Isolation and characterization of C-reactive protein and serum amyloid P component in the rat","volume":"45","author":"de Beer","year":"1982","journal-title":"Immunology"},{"key":"2021113011234377800_B7","doi-asserted-by":"publisher","first-page":"H1795","DOI":"10.1152\/ajpheart.00001.2010","article-title":"Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction","volume":"299","author":"Takahashi","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011234377800_B8","doi-asserted-by":"publisher","first-page":"353614","DOI":"10.1155\/2014\/353614","article-title":"Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models","volume":"2014","author":"Szalai","year":"2014","journal-title":"Mediators Inflamm."},{"key":"2021113011234377800_B9","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1084\/jem.190.12.1733","article-title":"C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction","volume":"190","author":"Griselli","year":"1999","journal-title":"J. Exp. Med."},{"key":"2021113011234377800_B10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.110.164350","article-title":"Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome","volume":"57","author":"Pravenec","year":"2011","journal-title":"Hypertension"},{"key":"2021113011234377800_B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/cvr\/20.1.67","article-title":"Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischaemia","volume":"20","author":"Snoeckx","year":"1986","journal-title":"Cardiovasc. Res."},{"key":"2021113011234377800_B12","first-page":"124","article-title":"Antiarrhythmic effect of ischemic preconditioning in hearts of spontaneously hypertensive rats","volume":"2","author":"Kolar","year":"1997","journal-title":"Exp. Clin. Cardiol."},{"key":"2021113011234377800_B13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.33549\/physiolres.930998","article-title":"Tolerance to acute ischemia in adult male and female spontaneously hypertensive rats","volume":"56","author":"Besik","year":"2007","journal-title":"Physiol. Res."},{"key":"2021113011234377800_B14","doi-asserted-by":"publisher","first-page":"e101906","DOI":"10.1371\/journal.pone.0101906","article-title":"Fumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats","volume":"9","author":"Silhavy","year":"2014","journal-title":"PLoS ONE"},{"key":"2021113011234377800_B15","doi-asserted-by":"publisher","first-page":"e0150924","DOI":"10.1371\/journal.pone.0150924","article-title":"Effects of metformin on tissue oxidative and dicarbonyl stress in transgenic spontaneously hypertensive rats expressing human C-reactive protein","volume":"11","author":"Malinska","year":"2016","journal-title":"PLoS ONE"},{"key":"2021113011234377800_B16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s003950200007","article-title":"Cardioprotective effects of chronic hypoxia and preconditioning are not additive","volume":"97","author":"Neckar","year":"2002","journal-title":"Basic Res. Cardiol."},{"key":"2021113011234377800_B17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1152\/physiolgenomics.00083.2011","article-title":"CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis","volume":"44","author":"Neckar","year":"2012","journal-title":"Physiol. Genomics"},{"key":"2021113011234377800_B18","first-page":"597","article-title":"Effects of adaptation to intermittent high altitude hypoxia on ischemic ventricular arrhythmias in rats","volume":"49","author":"Asemu","year":"2000","journal-title":"Physiol. Res."},{"key":"2021113011234377800_B19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00424-013-1281-5","article-title":"Transgenic rescue of defective Cd36 enhances myocardial adenylyl cyclase signaling in spontaneously hypertensive rats","volume":"465","author":"Klevstig","year":"2013","journal-title":"Pflugers Arch."},{"key":"2021113011234377800_B20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature10490","article-title":"Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function","volume":"478","author":"McDermott-Roe","year":"2011","journal-title":"Nature"},{"key":"2021113011234377800_B21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/HYPERTENSIONAHA.118.09909","article-title":"Hemodynamic response to gabapentin in conscious spontaneously hypertensive rats","volume":"72","author":"Behuliak","year":"2018","journal-title":"Hypertension"},{"key":"2021113011234377800_B22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2010.05.038","article-title":"Heart rate correction of the QT duration in rats","volume":"641","author":"Kmecova","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"2021113011234377800_B23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.33549\/physiolres.933537","article-title":"Propofol-induced mitochondrial and contractile dysfunction of the rat ventricular myocardium","volume":"65","author":"Grundmanova","year":"2016","journal-title":"Physiol. Res."},{"key":"2021113011234377800_B24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fphys.2016.00367","article-title":"Changes in myocardial composition and conduction properties in rat heart failure model induced by chronic volume overload","volume":"7","author":"Sedmera","year":"2016","journal-title":"Front. Physiol."},{"key":"2021113011234377800_B25","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3389\/fphys.2018.01876","article-title":"Trabecular architecture determines impulse propagation through the early embryonic mouse heart","volume":"9","author":"Olejnickova","year":"2019","journal-title":"Front. Physiol."},{"key":"2021113011234377800_B26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissue","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"2021113011234377800_B27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1734-1140(12)70775-2","article-title":"Antiarrhythmic effect of prolonged morphine exposure is accompanied by altered myocardial adenylyl cyclase signaling in rats","volume":"64","author":"Skrabalova","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"2021113011234377800_B28","doi-asserted-by":"publisher","first-page":"40381","DOI":"10.1038\/srep40381","article-title":"Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors","volume":"7","author":"Jakubik","year":"2017","journal-title":"Sci. Rep."},{"key":"2021113011234377800_B29","doi-asserted-by":"publisher","first-page":"463123","DOI":"10.1155\/2014\/463123","article-title":"Adenylyl cyclase signaling in the developing chick heart: the deranging effect of antiarrhythmic drugs","volume":"2014","author":"Hejnova","year":"2014","journal-title":"Biomed Res. Int."},{"key":"2021113011234377800_B30","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/jcsm.12631","article-title":"Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin","volume":"11","author":"Janovska","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2021113011234377800_B31","doi-asserted-by":"publisher","first-page":"e0190632","DOI":"10.1371\/journal.pone.0190632","article-title":"Obesogenic diets alter metabolism in mice","volume":"13","author":"Showalter","year":"2017","journal-title":"PLoS ONE"},{"key":"2021113011234377800_B32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.bbalip.2011.06.005","article-title":"High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines","volume":"1811","author":"Dumlao","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113011234377800_B33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.mam.2018.01.004","article-title":"Omega-3 fatty acids and adipose tissue biology","volume":"64","author":"Kuda","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"2021113011234377800_B34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat. Methods"},{"key":"2021113011234377800_B35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1042\/CS20170083","article-title":"Selective replacement of mitochondrial DNA increases cardioprotective effect of chronic continuous hypoxia in spontaneously hypertensive rats","volume":"131","author":"Neckar","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011234377800_B36","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/01.RES.49.4.980","article-title":"Effects of hypoxia on the closing pressure of the canine systemic arterial circulation","volume":"49","author":"Sylvester","year":"1981","journal-title":"Circ. Res."},{"key":"2021113011234377800_B37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/01.RES.67.1.209","article-title":"Starling resistor versus compliance. Which explains the zero-flow pressure of a dynamic arterial pressure-flow relation?","volume":"67","author":"Magder","year":"1990","journal-title":"Circ. Res."},{"key":"2021113011234377800_B38","doi-asserted-by":"publisher","first-page":"H1883","DOI":"10.1152\/ajpheart.00617.2006","article-title":"Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning","volume":"292","author":"Schmidt","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011234377800_B39","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCRESAHA.118.312784","article-title":"Reflection of cardioprotection by remote ischemic perconditioning in attenuated ST-segment elevation during ongoing coronary occlusion in pigs: evidence for cardioprotection from ischemic injury","volume":"122","author":"Kleinbongard","year":"2018","journal-title":"Circ. Res."},{"key":"2021113011234377800_B40","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1007\/BF02562284","article-title":"n-3 fatty acids in the prevention of cardiac arrhythmias","volume":"34","author":"Leaf","year":"1999","journal-title":"Lipids"},{"key":"2021113011234377800_B41","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1007\/s11745-001-0692-x","article-title":"Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models","volume":"36","author":"McLennan","year":"2001","journal-title":"Lipids"},{"key":"2021113011234377800_B42","first-page":"823","article-title":"Dietary polyunsaturated fatty acids alter myocardial protein kinase C expression and affect cardioprotection induced by chronic hypoxia","volume":"232","author":"Hlavackova","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"2021113011234377800_B43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s13105-019-00670-y","article-title":"About the controversies of the cardioprotective effect of n-3 polyunsaturated fatty acids (PUFAs) between animal studies and clinical meta-analyses: a review with several strategies to enhance the beneficial effects of n-3 PUFAs","volume":"75","author":"Demaison","year":"2019","journal-title":"J. Physiol. Biochem."},{"key":"2021113011234377800_B44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/01.CIR.0000152099.87287.83","article-title":"Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men","volume":"111","author":"Mozaffarian","year":"2005","journal-title":"Circulation"},{"key":"2021113011234377800_B45","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIR.0000000000000574","article-title":"Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: a science advisory from the American Heart Association","volume":"138","author":"Rimm","year":"2018","journal-title":"Circulation"},{"key":"2021113011234377800_B46","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ejcn.2011.195","article-title":"Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men","volume":"66","author":"Reinders","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"key":"2021113011234377800_B47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00380-013-0384-4","article-title":"Relation of omega-3 fatty acid and C-reactive protein to peripheral artery disease in patients with coronary artery disease","volume":"29","author":"Sugiura","year":"2014","journal-title":"Heart Vessels"},{"key":"2021113011234377800_B48","doi-asserted-by":"publisher","first-page":"H93","DOI":"10.1152\/ajpheart.00823.2014","article-title":"Effect of docosahexaenoic acid monoacylglyceride on systemic hypertension and cardiovascular dysfunction","volume":"309","author":"Morin","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011234377800_B49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat. Genet."},{"key":"2021113011234377800_B50","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.yjmcc.2009.08.017","article-title":"Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches","volume":"47","author":"Li","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113011234377800_B51","doi-asserted-by":"publisher","first-page":"e73490","DOI":"10.1371\/journal.pone.0073490","article-title":"CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy","volume":"8","author":"Westphal","year":"2013","journal-title":"PLoS ONE"},{"key":"2021113011234377800_B52","doi-asserted-by":"publisher","first-page":"e003721","DOI":"10.1161\/CIRCEP.115.003721","article-title":"Molecular mechanisms and new treatment paradigm for atrial fibrillation","volume":"9","author":"Sirish","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"2021113011234377800_B53","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1097\/HJH.0000000000001708","article-title":"Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension","volume":"36","author":"Cervenka","year":"2018","journal-title":"J. Hypertens."},{"key":"2021113011234377800_B54","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2013.01.034","article-title":"Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients","volume":"227","author":"Schuck","year":"2013","journal-title":"Atherosclerosis"},{"key":"2021113011234377800_B55","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/cvr\/27.5.703","article-title":"Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease","volume":"27","author":"Curtis","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"2021113011234377800_B56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/cvr\/27.5.693","article-title":"Endogenous myocardial protective (antiarrhythmic) substances","volume":"27","author":"Parratt","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"2021113011234377800_B57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1476-5381.1985.tb09457.x","article-title":"AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds","volume":"86","author":"Coker","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"2021113011234377800_B58","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0002-8703(89)90622-4","article-title":"The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models","volume":"117","author":"O'Connor","year":"1989","journal-title":"Am. Heart J."},{"key":"2021113011234377800_B59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1476-5381.1983.tb09359.x","article-title":"Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size","volume":"78","author":"Johnston","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"2021113011234377800_B60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00005344-198307000-00008","article-title":"Prostacyclin-antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds","volume":"5","author":"Coker","year":"1983","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021113011234377800_B61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF02190604","article-title":"Protective effect of 7-oxo-prostacyclin on myocardial function and metabolism during postischemic reperfusion and calcium paradox","volume":"86","author":"Ravingerova","year":"1991","journal-title":"Basic Res. Cardiol."},{"key":"2021113011234377800_B62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1055\/s-2006-960774","article-title":"The effects of tetramethylpyrazine on the incidence of arrhythmias and the release of PGI2 and TXA2 in the ischemic rat heart","volume":"65","author":"Feng","year":"1999","journal-title":"Planta Med."},{"key":"2021113011234377800_B63","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm1231","article-title":"Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia","volume":"11","author":"Takayama","year":"2005","journal-title":"Nat. Med."},{"key":"2021113011234377800_B64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.phrs.2006.01.004","article-title":"Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats","volume":"53","author":"Rossoni","year":"2006","journal-title":"Pharmacol. Res."},{"key":"2021113011234377800_B65","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1124\/jpet.109.157677","article-title":"Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway","volume":"331","author":"Wacker","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021113011234377800_B66","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.clnu.2014.09.011","article-title":"Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients","volume":"34","author":"Pignatelli","year":"2015","journal-title":"Clin. Nutr."},{"key":"2021113011234377800_B67","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1538-7836.2009.03511.x","article-title":"Aspirin reduces the prothrombotic activity of C-reactive protein","volume":"7","author":"Grad","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"2021113011234377800_B68","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ahj.2004.08.030","article-title":"Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment","volume":"149","author":"Ikonomidis","year":"2005","journal-title":"Am. Heart J."},{"key":"2021113011234377800_B69","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.phrs.2010.07.005","article-title":"Induction of hemeoxygenase-1 attenuates the hypertension and renal inflammation in spontaneously hypertensive rats","volume":"62","author":"Elmarakby","year":"2010","journal-title":"Pharmacol. Res."},{"key":"2021113011234377800_B70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1042\/CS20060132","article-title":"C-reactive protein modulates vagal heart rate control in patients with coronary artery disease","volume":"112","author":"Nolan","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011234377800_B71","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1172\/JCI113528","article-title":"Impaired cardiac muscarinic receptor function in dogs with heart failure","volume":"81","author":"Vatner","year":"1988","journal-title":"J. Clin. Invest."},{"key":"2021113011234377800_B72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1590\/bjpt-rbf.2014.0124","article-title":"Interval training based on ventilatory anaerobic threshold increases cardiac vagal modulation and decreases high-sensitivity c-reative protein: randomized clinical trial in coronary artery disease","volume":"19","author":"Tamburus","year":"2015","journal-title":"Braz. J. Phys. Ther."},{"key":"2021113011234377800_B73","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCHEARTFAILURE.109.873968","article-title":"Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model","volume":"2","author":"Zhang","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"2021113011234377800_B74","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1113\/EP085518","article-title":"Subthreshold vagal stimulation suppresses ventricular arrhythmia and inflammatory response in a canine model of acute cardiac ischaemia and reperfusion","volume":"101","author":"Zhang","year":"2016","journal-title":"Exp. Physiol."},{"key":"2021113011234377800_B75","doi-asserted-by":"publisher","first-page":"e86715","DOI":"10.1172\/jci.insight.86715","article-title":"Parasympathetic dysfunction and antiarrhythmic effect of vagal nerve stimulation following myocardial infarction","volume":"2","author":"Vaseghi","year":"2017","journal-title":"JCI Insight"},{"key":"2021113011234377800_B76","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ehj.2003.12.003","article-title":"Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease","volume":"25","author":"Sajadieh","year":"2004","journal-title":"Eur. Heart J."},{"key":"2021113011234377800_B77","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/FJC.0000000000000509","article-title":"Low-dose aspirin inhibits cardiac sympathetic activation and vagal withdrawal response to morning rising","volume":"70","author":"Yasumasu","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021113011234377800_B78","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2459\/01.JCM.0000289276.10675.a1","article-title":"Autonomic nervous system, heart rate variability and n-3 fatty acids","volume":"8","author":"Christensen","year":"2007","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"2021113011234377800_B79","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/1535370217743919","article-title":"Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application","volume":"243","author":"Mallet","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"2021113011234377800_B80","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.celrep.2018.04.104","article-title":"Accumulation of succinate in cardiac ischemia primarily occurs via canonical krebs cycle activity","volume":"23","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"2021113011234377800_B81","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacbts.2018.04.005","article-title":"Fatty acids prevent hypoxia-inducible factor-1\u03b1 signaling through decreased succinate in diabetes","volume":"3","author":"Dodd","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"2021113011234377800_B82","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/apha.12613","article-title":"Adaptive response to hypoxia and remote ischaemia pre-conditioning: a new hypoxia-inducible factors era in clinical medicine","volume":"216","author":"Heyman","year":"2016","journal-title":"Acta Physiol. (Oxf.)"},{"key":"2021113011234377800_B83","doi-asserted-by":"publisher","first-page":"H1148","DOI":"10.1152\/ajpheart.00726.2017","article-title":"Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1\u03b1 via downregulation of prolyl hydroxylase 3","volume":"315","author":"Neckar","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011234377800_B84","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1006\/jmcc.1997.0550","article-title":"Cardioprotection by orotic acid: metabolism and mechanism of action","volume":"29","author":"Richards","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113011234377800_B85","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1113\/expphysiol.2009.049452","article-title":"Amino acid transamination is crucial for ischaemic cardioprotection in normal and preconditioned isolated rat hearts\u2013focus on L-glutamate","volume":"95","author":"L\u00f8fgren","year":"2010","journal-title":"Exp. Physiol."},{"key":"2021113011234377800_B86","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/cvr\/cvx024","article-title":"Cardiac mGluR1 metabotropic receptors in cardioprotection","volume":"113","author":"Vincent","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"2021113011234377800_B87","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0891-5849(02)01020-1","article-title":"Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration","volume":"33","author":"Teng","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"2021113011234377800_B88","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.intimp.2016.11.018","article-title":"Pterostilbene protects against myocardial ischemia\/reperfusion injury via suppressing oxidative\/nitrative stress and inflammatory response","volume":"43","author":"Yu","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"2021113011234377800_B89","doi-asserted-by":"publisher","first-page":"H1968","DOI":"10.1152\/ajpheart.00250.2002","article-title":"dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts","volume":"283","author":"Zou","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011234377800_B90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejphar.2018.04.019","article-title":"Treatment with D-\u03b2-hydroxybutyrate protects heart from ischemia\/reperfusion injury in mice","volume":"829","author":"Yu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"2021113011234377800_B91","doi-asserted-by":"publisher","first-page":"567","DOI":"10.33549\/physiolres.932338","article-title":"Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats","volume":"61","author":"Snorek","year":"2012","journal-title":"Physiol. Res."},{"key":"2021113011234377800_B92","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-019-0179-0","article-title":"Animal models of arrhythmia: classic electrophysiology to genetically modified large animals","volume":"16","author":"Clauss","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"2021113011234377800_B93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0008-6363(98)00083-2","article-title":"Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation","volume":"39","author":"Curtis","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"2021113011234377800_B94","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0022-2828(87)80585-0","article-title":"Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat","volume":"19","author":"Curtis","year":"1987","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113011234377800_B95","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.1991.03460060094032","article-title":"Current treatment of patients surviving out-of-hospital cardiac arrest","volume":"265","author":"Brooks","year":"1991","journal-title":"JAMA"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/17\/2143\/920698\/cs-2021-0648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/17\/2143\/920698\/cs-2021-0648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:19:24Z","timestamp":1638274764000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/135\/17\/2143\/229720\/Excess-ischemic-tachyarrhythmias-trigger"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":95,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021,9,17]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20210648","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,9]]}}}